Sanofi-aventis U.S. Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Sanofi-aventis U.S. Inc.

Sort by

Viewing results 1‒25 of 343

Neglected tropical diseases
FT Health: New WHO chief faces tough challenges
...(FT) UK care crisis The general election campaign was dominated by a Conservative U-turn over social care plans, dubbed a “dementia tax” by opponents....
May 26, 2017
EU business regulation
German group’s bid defence tests EU takeover rules
...While not seen in Germany before, Braas’s tactic has some similarities to that deployed by French drugmaker Aventis in 2004, in an attempt to avoid being acquired by Sanofi in a $60bn deal....
December 8, 2016
FT Live
FTWeekend Festival: U.S. edition
The Saturday where the Financial Times Weekend paper comes to life
Saturday, 10 May 2025The REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
The Top LineMatthew Vincent
Verizon takes off on a flight of fancy with Yahoo acquisition
...Sanofi and Aventis merged to take on US pharma, but have not caught Pfizer. Nor have Glaxo and SmithKline Beecham....
July 29, 2016
US & Canadian companies
FDA performs U-turn over restriction of pain drug
...not a household name, its fight against the FDA was backed by a consortium of 11 of the biggest names in the pharmaceuticals industry — including Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis and Sanofi...
December 15, 2015
FT AlphavilleDavid Keohane
The 6am London Cut
...(Reuters) “Exelon, the largest U.S. nuclear operator, has agreed to buy Pepco Holdings Inc. for more than $5.4 billion in cash, according to people familiar with the transaction.”...
April 30, 2014
Pharmaceuticals sector
Big drugmakers such as Novartis turn from expansion to divestment
...Expansion by larger drug companies was the norm at the start of this century, from the merger that created GlaxoSmithKline in 2000 and the $67bn purchase of Aventis by Sanofi in 2004, to Pfizer’s $68bn paid...
November 19, 2013
FT Live
Decarbonising India's Industries
Unlocking the technologies and capital required to accelerate progress
Tuesday, 11 JuneDigital Conference
beyondbricsMergers & Acquisitions
Big Pharma says Olá to Brazil
...Amgen, Sanofi-Aventis and Pfizer have all made acquisitions in this area in Brazil....
April 17, 2013
European companies
Roche executive named AstraZeneca chief
...Mr Soriot, 53, a Frenchman who trained as a veterinary surgeon before obtaining an MBA, worked for much of his career in Asia for Roussel Uclaf, Hoechst and Aventis, which became part of Sanofi in 2004....
August 28, 2012
FT AlphavilleEquities
SABMiller leads US corporate bond sale surge
...It was the largest bond sale in the US since March 2011, when Sanofi-Aventis sold $7bn, Dealogic said....
January 11, 2012
Retail & Consumer industry
SABMiller leads US corporate bond sale surge
...It was the largest bond sale in the US since March 2011, when Sanofi-Aventis sold $7bn, Dealogic said....
January 11, 2012
LexUK companies
Vodafone: right call
...That is good news for the backlog of other companies awaiting similar appeals, including brewer SABMiller, US wireless operator AT&T, and French drugmaker Sanofi-Aventis....
January 20, 2012
US & Canadian companies
Shire leads London’s blue-chip fallers
...Shire had little incentive to fund the extra tests as production at Genzyme, now owned by Sanofi-Aventis, would return to normal later this year, analysts said....
March 15, 2012
US & Canadian companies
HP adds activist investor Whitworth to board
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
November 18, 2011
IPOs
London headlines
...Aventis Pharma seals deal to buy Universal Medicare Aventis Pharma, a part of French drug maker Sanofi has entered into a definitive agreement to acquire Universal Medicare’s marketing and distribution business...
August 25, 2011
LexUK companies
European pharmaceuticals
...Sanofi-Aventis investors, meanwhile, will pore over the impact of its recently lost patents. Stepping back, investors should watch for the impact of recent government cuts to drug prices....
October 11, 2011
FT Live
Investing in America
Foreign companies as drivers of US growth, resilience and competitiveness
Tuesday, 10 DecemberHybrid Conference
US downturn
IT departments must deliver more for less
...For example, Sanofi-Aventis, the French multinational pharmaceutical company, is using Microsoft’s SharePoint to revamp its R&D process....
December 6, 2011
European companies
Sanofi eyes assets for animal health unit
...Sanofi-Aventis plans to cut costs and expand its animal health business through acquisitions as it fully integrates Merial after the collapse of its longstanding joint venture with Merck of the US....
May 10, 2011
Currencies
AstraZeneca indicted in Serbian corruption case
...The action follows the arrests last year in Belgrade of senior officials at the Serbian Institute for Oncology and Radiology, as well as the heads of the Belgrade offices of AstraZeneca, Roche, Actavis, Sanofi-Aventis...
October 27, 2011
US & Canadian companies
Merck and Sanofi scrap joint venture
...Merck and Sanofi-Aventis have abandoned plans to create the world’s largest animal health company, scrapping a joint venture with combined sales of $5.5bn that was announced a year ago, in a move they blamed...
March 22, 2011
FT AlphavilleCardiff Garcia
Sanofi agrees $20.1bn Genzyme takeover
...Sanofi-Aventis brought an end to its protracted pursuit of Genzyme with an agreed $20.1bn cash takeover of the US biotech company, coupled with additional conditional payments over the next decade, reports...
February 16, 2011
FT AlphavilleGwen Robinson
Sanofi-Genzyme: end of a saga?
...From Market Watch: French pharmaceuticals major Sanofi-Aventis SA confirmed Wednesday it has struck a deal to buy U.S. peer Genzyme Corp....
February 16, 2011
European companies
Sanofi-Aventis sounds profit caution
...Sanofi-Aventis cautioned that 2011 earnings were likely to be down by as much as 10 per cent from last year’s €7.06 ($9.68) a share as a result of increased pricing pressure and threats from generic competition...
February 10, 2011
US & Canadian companies
Investors place discount on Sanofi’s offer
...He said that there could also be legal disputes over Sanofi-Aventis’ implementation of its pledge for “diligent efforts” to develop Lemtrada....
February 18, 2011
US & Canadian companies
Roche and Merck tie up on hepatitis treatment
...Merck maintains a development and marketing partnership for vaccines in Europe with Sanofi-Aventis, and until the recent collapse of talks it was planning a renewal of Merial, its long-standing partnership...
May 17, 2011
Pharmaceuticals sector
Hostile Prince Valeant battles the Cephalon
...Such thinking has guided it through a flurry of more than a dozen deals and underpins its $5.7bn bid for Cephalon, which would be the largest hostile takeover in healthcare since Sanofi-Aventis bagged Genzyme...
March 30, 2011

Previous pagePage 1 of 14Next page